Indee Labs · Sep 2024
Indee Labs says its Hydropore platform enabled sequential multiplex editing of T cells with improved viability and proliferation versus nucleofection; the post cites planned validation with CellChorus.
Enabling T cell immunotherapy discovery, development and manufacturing
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Indee Labs is a Berkeley-based biotech company building Hydropore™, a patented non-viral microfluidic vortex shedding platform for engineered cell therapies and intracellular delivery into immune cells.
Primary product
Hydropore™ non-viral intracellular delivery platform
Founded
2015
Headquarters
Berkeley, California, United States
Team size
1-10 employees
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
cell therapy tools / non-viral gene delivery
Offices
Open Positions
0 jobs at Indee Labs
No open positions
Check back later for new openings